BeOne Medicines (ONC) Other Non-Current Assets (2015 - 2026)
BeOne Medicines' (ONC) quarterly Other Non-Current Assets came in at $109.6 million in Q2 2026, down 32.24% year-over-year from $161.7 million in Q2 2025, and up 5.12% quarter-over-quarter from $104.2 million in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Other Non-Current Assets (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Other Non-Current Assets for 12 consecutive years, with $109.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 32.24% year-over-year to $109.6 million in Q2 2026; TTM through Jun 2026 was $109.6 million, a 32.24% decrease from a year earlier, with the FY2025 full-year figure at $102.4 million, down 36.18% from the prior year.
- Other Non-Current Assets was $109.6 million for Q2 2026 at BeOne Medicines, up from $104.2 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $201.2 million in Q3 2024 and troughed at $3.9 million in Q2 2022.
- A 5-year average of $135.5 million and a median of $144.2 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 60.32% in 2022 and soared 3645.85% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $175.7 million in 2022, then slipped by 28.65% to $125.4 million in 2023, then gained by 28.02% to $160.5 million in 2024, then sank by 36.18% to $102.4 million in 2025, then climbed by 6.99% to $109.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $109.6 million (Q2 2026), $104.2 million (Q1 2026), and $102.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 109.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109.58 Mn |
| Mar 31, 2026 | 104.24 Mn |
| Dec 31, 2025 | 102.42 Mn |
| Sep 30, 2025 | 136.20 Mn |
| Jun 30, 2025 | 161.72 Mn |
| Mar 31, 2025 | 149.89 Mn |
| Dec 31, 2024 | 160.49 Mn |
| Sep 30, 2024 | 201.17 Mn |
| Jun 30, 2024 | 199.32 Mn |
| Mar 31, 2024 | 199.02 Mn |
| Dec 31, 2023 | 125.36 Mn |
| Sep 30, 2023 | 140.90 Mn |
| Jun 30, 2023 | 147.55 Mn |
| Mar 31, 2023 | 173.37 Mn |
| Dec 31, 2022 | 175.69 Mn |
| Sep 30, 2022 | 140.55 Mn |
| Jun 30, 2022 | 3.94 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 163.05 Mn |
| Sep 30, 2021 | 6.06 Mn |
API Access
BeOne Medicines Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();